Related Experiment Video
Updated: Jul 21, 2025

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Benefits of routine probiotic supplementation in preterm infants
C P Rath1,2, G Athalye-Jape1,2, E Nathan3,4
1Neonatology Directorate, King Edward Memorial Hospital for Women, Subiaco, Western Australia, Australia.
Insights
Routine probiotic supplementation (RPS) for preterm infants continues to show sustained benefits. This study found that RPS significantly reduced necrotizing enterocolitis (NEC) and late-onset sepsis (LOS) in recent years.
Area of Science:
- Neonatal Medicine
- Pediatric Gastroenterology
- Microbiome Research
Background:
- Routine probiotic supplementation (RPS) was introduced for preterm infants in 2012.
- Previous studies demonstrated that RPS reduced necrotizing enterocolitis (NEC) and mortality.
- The current study aimed to assess the sustained benefits of RPS in the contemporary clinical setting.
Purpose of the Study:
- To evaluate if the benefits of routine probiotic supplementation (RPS) in preterm infants have been maintained over time.
- To compare outcomes of preterm infants across three epochs: pre-RPS, early RPS, and current RPS era.
Main Methods:
- A comparative study design was employed, analyzing data from three distinct epochs.
- Epoch 1: No RPS (December 2008 - November 2010).
- Epochs 2 & 3: With RPS (June 2012 - May 2014 and June 2014 - December 2019, respectively).
- Statistical analysis included multiple logistic and Cox regression models to compare infant outcomes.
Main Results:
- A total of 3072 preterm infants were analyzed across the three epochs.
- Infants in epoch 3 (<28 weeks gestation) showed significantly lower rates of NEC and late-onset sepsis (LOS) compared to epoch 1.
- Epoch 3 infants (<28 weeks and 28-32 weeks gestation) reached full feeds significantly earlier compared to epochs 1 and 2.
- LOS and age at full feeds were significantly lower in epoch 3 compared to epoch 2 for infants 28-32 weeks gestation.
Conclusions:
- The positive outcomes associated with routine probiotic supplementation (RPS) in preterm infants are sustained in the current era.
- RPS remains an effective intervention for reducing NEC and LOS, and improving feeding tolerance in vulnerable preterm populations.
Aim:
We introduced routine probiotic supplementation (RPS) of preterm infants in June 2012. We previously reported that RPS reduced the incidence of necrotising enterocolitis (NEC) and mortality in such infants. In this study, we assessed if the benefits of RPS were sustained for infants in the current era.
Method:
We compared the outcomes of preterm infants in recent epoch 3 (RPS, 1st June 2014 to 31st December 2019) versus epoch 2 (RPS, 1st June 2012 to 31st May 2014) and epoch 1 (no RPS, 1st December 2008 to 30th November 2010). Multiple logistic and Cox regression models were used to compare the outcomes.
Results:
There were 645 infants in epoch 1, 712 in epoch 2 and 1715 in epoch 3. Age at full feeds was significantly lower in epoch 3 vs. 2 and epoch 3 vs. 1 in infants <28 weeks of gestation. NEC and late-onset sepsis (LOS) were significantly lower in epoch 3 vs. 1 in infants <28 weeks. LOS and age at full feeds were significantly lower in epoch 3 vs. 2 and epoch 3 vs. 1 in infants with gestation 28 to 32 weeks.
Conclusion:
The benefits associated with RPS were sustained during epoch 3.
More Related Videos
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
04:16Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
Published on: February 7, 2025